Idera Sues USPTO To Extend Cancer Treatment Patents

By Leigh Kamping-Carder

Law360, New York (February 08, 2010, 4:16 PM ET) -- Citing the recent decision in Wyeth v. Kappos, Idera Pharmaceuticals Inc. has sued the U.S. Patent and Trademark Office, claiming the patent authority miscalculated an extension for two of its patents covering a cancer treatment by a year and a half.

In an amended complaint filed Wednesday in the U.S. District Court for the District of Columbia, Idera said that David J. Kappos, director of the USPTO, had approved an extension for the patents using a method recently invalidated by a federal appeals court.

According to...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles